- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/04 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 207/04
Total number of patents in this class: 224
10-year publication summary
|
23
|
11
|
25
|
15
|
11
|
12
|
11
|
8
|
16
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21303 |
6 |
| Bristol-myers Squibb Company | 4742 |
4 |
| ExxonMobil Research And Engineering Company | 2422 |
4 |
| Allergan, Inc. | 2167 |
3 |
| The General Hospital Corporation | 4870 |
3 |
| Acuitas Therapeutics Inc. | 137 |
3 |
| BioTheryX, Inc. | 98 |
3 |
| ChemoCentryx, Inc. | 361 |
3 |
| Innospec Limited | 408 |
3 |
| Korea Research Institute of Chemical Technology | 1469 |
3 |
| Mitobridge, Inc. | 31 |
3 |
| PIMCO 2664 Limited | 20 |
3 |
| Research & Business Foundation Sungkyunkwan University | 2171 |
3 |
| The Salk Institute for Biological Studies | 450 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 852 |
3 |
| Tetra Technologies, Inc. | 107 |
3 |
| Morphic Therapeutic, Inc. | 60 |
3 |
| Celltaxis, LLC | 29 |
3 |
| Samsung Electronics Co., Ltd. | 157719 |
2 |
| Glaxosmithkline LLC | 528 |
2 |
| Other owners | 161 |